Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Application and Mechanism of Cord Blood Mononuclear Cells in the Treatment of Ischemic Bowel Disease

NCT05560672 is registered in ClinicalTrials.gov with Qianfoshan Hospital as lead sponsor.

NCT NCT05560672
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05560672 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Application and Mechanism of Cord Blood Mononuclear Cells in the Treatment of Ischemic Bowel Disease
Lead sponsor
Qianfoshan Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
September 1, 2019
Completion date
September 1, 2024
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic bowel disease